ENA Antibodies Screen

Immunology


Description

The detection of antinuclear antibodies (ANAs) has long been an important tool in the diagnosis of systemic rheumatic diseases. The antigens used in their detection are purified by the saline extraction of human or animal nuclei, this has led to them being called extractable nuclear antigens (ENA). The most commonly measured ENA specifications are anti-SS-A/Ro, anti-SS-B/La, anti-Sm, anti-Sm/RNP anti-Jo-1 and anti-SCL-70. Individual ENA types are performed by line blot if the ELISA ENA screen is positive. Ro and La are a heterogeneous antigenic complex made up of 52 kDa Ro, 60 kDa Ro and four small RNA particles [1]. Anti-Ro are the most common ENA specificity amongst autoimmune diseases. They can be seen in Sjogren's syndrome, SLE, cutaneous lupus erythematosus, neonatal lupus and primary biliary cirrhosis [1]. Anti-La (SS-B) antibodies are found mainly in Sjogren's syndrome and sometimes in SLE [1]. Anti-Sm (Smith) antibodies are specific for SLE (5-30%) and are more prevalent in Afro-carribeans [2]. Anti-RNP antibodies can be seen in mixed connective tissue disease with a lower frequency in SLE [2]. These antibodies are associated with a positive coarse speckled antinuclear antibody. Anti-Scl-70 antibodies are found in progressive systemic sclerosis and in limited scleroderma [3]. Anti-Jo-1 antibodies are specific for adults with autoimmune myositis and idiopathic inflammatory myopathies [4]. The antinuclear antibody result is usually negative although a faint cytoplasmic staining may be seen.


Indications

Connective tissue disease, systemic lupus erythematosus (SLE), Sjogren's syndrome.


Sample Type

2mL Serum (Gel 5mL Yellow tube). Requests from outside Sheffield: Transport at ambient temperature via Royal Mail or Courier.


Reference Range

Normal result = Negative.


Turnaround Time

Within 5 days


Testing Frequency

Weekly


References

Damosieaux JGMC, Cohen Tervaert JW. From ANA to ENA: How to proceed? Autoimmunity Reviews. 2006. 5:10-17.
Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005. 38(1):55-63. [Ref 1]
Basu D, Reveille JD. Anti-scl-70. Autoimmunity. 2005. 38(1):65-72. [Ref 3]
Migliorini P, et al. Anti-Sm and anti-RNP antibodies. Autoimmunity. 2005. 38(1):47-54. [Ref 2]
Zampieri S, et al. Anti-Jo-1 antibodies. Autoimmunity. 2005. 38(1):73-78. [Ref 4]
Kavanagh AF, Solomon DH. Guidelines for immunologic laboratory testing in the rheumatic diseases:anti-DNA antibody tests. Arthritis and Rheumatism. 2002. 47(5):546-555.
Egner W. The use of laboratory tests in the diagnosis of SLE. Journal of Clinical Pathology. 2000. 53:424-432.


See Also

ANA; ENA types

Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.

Your contact for this test

team

Clare Del-Duca BSc (Hons) Biomedical Science, MSc Pathological Science

Laboratory Manager - Immunology and Protein Reference Unit

You are enquiring about

ENA Antibodies Screen